Thoratec Corp (THOR) 63.50 $THOR United States
Post# of 273257
Posted On: 09/03/2016 1:04:30 PM
Thoratec Corp (THOR) 63.50 $THOR
United States Electromedical and Electrotherapeutic Apparatus Market Report 2016 - Analysis And Forecast to 2020
M2 - Mon Jan 25, 9:03AM CST
Research and Markets (http://www.researchandmarkets.com/research/6mvcjq/u_s) has announced the addition of the "U.S. Electromedical And Electrotherapeutic Apparatus Market - Analysis And Forecast to 2020" report to their offering. The report provides an in-depth analysis of the U.S. Electromedical And Electrotherapeutic Apparatus market. It presents the latest data of the market size and volume, domestic production, exports and imports, price dynamics and turnover in the industry. In addition, the report contains insightful information about the industry, including industry life cycle, business locations, productivity, employment and many other crucial aspects. The Company Profiles section contains relevant data on the major players in the industry. Product coverage: - Electromedical equipment (including diagnostic, therapeutic, and patient monitoring equipment), excluding ionizing radiation equipment - Electronic hearing aids, complete units - Electromedical and electrotherapeutic apparatus manufacturing Key Topics Covered: 1. Introduction 2. Executive Summary 3. Market Overview 4. Domestic Production 5. Imports 6. Exports 7. Competitive Landscape 8. Company Profiles - St. Jude Medical - Zimmer Biomet Holdings - Varian Medical Systems - Medtronic - Hologic - Abbott Vascular - Zoll Medical Corporation - Cyberonics - Fujifilm Sonosite - Biomerieux - Masimo Corporation - Starkey Laboratories - Volcano Corporation - Philips Ultrasound - Thoratec Corporation - Nxstage Medical - Danaher Corporation - Abiomed - GE Medical Systems Information Technologies - Natus Medical Incorporated - Conmed Corporation - Pacesetter - Amplifon (usa) - Zimmer - Cynosure - Mindray Ds Usa - Orchid Orthopedic Solutions - Zoll Services - Datex-Ohmeda - Medtronic Minimed - Terumo Cardiovascular Systems Corporation - Nellcor Puritan Bennett Incorporated - Cardiac Pacemakers - Halyard Sales For more information visit http://www.researchandmarkets.com/research/6mvcjq/u_s
ZBH: 129.40 (+1.05), MASI: 59.90 (+0.47), MDT: 87.32 (+0.34), MDSY: 1.30 (-0.08), DHR: 81.19 (-0.25), CYBX: 69.95 (+0.86), BABY: 40.64 (+0.93), VAR: 96.41 (+0.52), VOLC: 17.99 (+0.01), STJ: 78.65 (+0.51), THOR: 63.50 (+0.05), HOLX: 38.51 (+0.05)
Global Bio-Implant Market 2016-2021 - Increasing awareness about cosmetic implants giving rise to global bio-implant market
M2 - Wed Jan 20, 10:27AM CST
Research and Markets (http://www.researchandmarkets.com/research/7jx486/global) has announced the addition of the "Global Bio-Implant Market, By Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation And Forecast 2015 - 2021" report to their offering. Global bio-implant market is growing at a CAGR of 8% from 2015-2021 The market is driven by various factors which include global rise in adoption of bio-implants, increase in number of people suffering from disabilities. It is giving rise to higher number of amputation. Rising incidence and prevalence rate of CVD, CHD and other heart diseases is also driving the market growth. Additionally, with increasing adoption of prosthetic limbs across geographies and rise in awareness about ear implants, pacemakers and other bio-implants are creating huge scope for global bio-implant market. Market is segmented on the basis of materials which include material such as ceramics, metal, alloys, polymers and others. Global bio-implant market by material and its type are extensively adopted by major hospitals and clinics for bio-implants. Further the market is segmented on the basis of bio implants type which includes CVD implants, spinal implants, orthopedic and trauma, dental, ophthalmic and neurostimulators. Stents, cardiac implant, ear implant are expected to contribute highest among all the segments of global bio-implant market. With the advancement in technology and innovation due to research and development segments such as dental implants, orthopedic implants are expected to contribute better in next few years. Bio-implant market consists of some major companies which includes Medtronic Inc, Abbot laboratories, AAP implantate AG, Bausch & Lomb incorporated, Biomet Inc, Biotronik SE & Co. KG, Boston scientific corporation, Crook group Inc, CR Bard Inc, Toshiba Corporation and others. Key Topics Covered: 1. Introduction 2. Market overview 3. Market determinants 4. Sector Analysis 5. Market Segmentation 6. Competitive Landscape 7. Geographical analysis 8. Company Profiles - Medtronic Inc - Abbot laboratories - AAP implantate AG - Bausch & Lomb incorporated - Biomet Inc - Biotronik SE & Co. KG - Boston scientific corporation - Crook group Inc - CR Bard Inc - Toshiba Corporation - GE healthcare - Edwards lifesciences corporation - Endo health solutions Inc - Johnson & Johnson - Philips corporation - Stryker corporation - Integral lifesciences holdings corporation - Integrated orbital implants - Lifenet health Inc - Mimedx group Inc - Orthofix international N.V. - Smith & nephew, PLC - Zimmer holdings - Wright medical group incorporated - WL Gore & associates Inc - Tornier N.V. - Thoratec corporation - St. Jude medical Inc - Sorin S.P.A. - Intuitive surgicals For more information visit http://www.researchandmarkets.com/research/7jx486/global
JNJ: 119.32 (+0.24), BCR: 221.21 (-0.29), MDT: 87.32 (+0.34), THOR: 63.50 (+0.05), SYK: 115.60 (+0.37)
St. Jude Medical Completes Acquisition of Thoratec
BusinessWire - Thu Oct 08, 3:38PM CDT
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced it has completed the previously announced acquisition of Thoratec Corporation, a worldwide leader in mechanical circulatory support (MCS) technology for the treatment of advanced heart failure (HF).
STJ: 78.65 (+0.51), THOR: 63.50 (+0.05)
Varian (VAR) Receives FDA Clearance, CE Mark for VitalBeam
Zacks Equity Research - Zacks Investment Research - Thu Oct 08, 11:50AM CDT
Varian Medical Systems, Inc. (VAR) recently announced that its VitalBeam platform has received FDA clearance as well as CE Mark.
MASI: 59.90 (+0.47), VAR: 96.41 (+0.52), THOR: 63.50 (+0.05), NUVA: 66.74 (+0.68)
Thoratec's shareholders approves its acquisition by St. Jude Medical
M2 - Thu Oct 08, 5:19AM CDT
Thoratec (NasdaqGS:THOR) said on Wednesday that all proposals necessary for its acquisition by St. Jude Medical were approved at the former's shareholder meeting.
STJ: 78.65 (+0.51), THOR: 63.50 (+0.05)
Thoratec Shareholders Approve St. Jude Medical's Acquisition Of Thoratec
PR Newswire - Wed Oct 07, 3:15PM CDT
Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts, announced today that all proposals necessary for St. Jude Medical, Inc.'s acquisition of Thoratec Corporation were approved by Thoratec Corporation's shareholders at its shareholder meeting held today.
STJ: 78.65 (+0.51), THOR: 63.50 (+0.05)
Varian to Add New Tool to Eclipse Treatment Planning System
Zacks Equity Research - Zacks Investment Research - Wed Oct 07, 1:15PM CDT
Varian Medical Systems Inc. (VAR) recently announced that it will incorporate a multi-criteria optimization (MCO) radiotherapy treatment planning tool into its Eclipse treatment planning system
MASI: 59.90 (+0.47), VAR: 96.41 (+0.52), THOR: 63.50 (+0.05), NUVA: 66.74 (+0.68)
IDEXX's Strong CAG Impresses, Stiff Competition Concerns
Zacks Equity Research - Zacks Investment Research - Tue Oct 06, 5:03PM CDT
On Oct 6 2015, we issued an updated research report on IDEXX Laboratories, Inc. (IDXX).
MASI: 59.90 (+0.47), GMED: 23.97 (+0.51), THOR: 63.50 (+0.05), IDXX: 114.09 (+0.93)
MedAssets: A Strong Buy on Extended Ties & Solid Q2 Results
Zacks Equity Research - Zacks Investment Research - Tue Oct 06, 1:35PM CDT
On Oct 6, Zacks Investment Research raised MedAssets, Inc. (MDAS) to a Zacks Rank #1 (Strong Buy).
MASI: 59.90 (+0.47), THOR: 63.50 (+0.05), MDAS: 31.35 (+0.01), NUVA: 66.74 (+0.68)
Accuray Extends Ties with RaySearch Laboratories, Stock Up
Zacks Equity Research - Zacks Investment Research - Tue Oct 06, 12:10PM CDT
Shares of Accuray Incorporated (ARAY) rallied 3.2% (or 17 cents) yesterday, following the news of its second long-term agreement with RaySearch Laboratories.
MASI: 59.90 (+0.47), THOR: 63.50 (+0.05), ARAY: 5.42 (+0.12), NUVA: 66.74 (+0.68)
Thoratec Highlights Clinical Events From The European Association For Cardio-Thoracic Surgery Conference
PR Newswire - Tue Oct 06, 7:21AM CDT
Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts, highlighted recent clinical presentations from the European Association for Cardio-Thoracic Surgery (EACTS) annual meeting in Amsterdam, including three presentations that build upon the positive initial data from the HeartMate 3 CE Mark trial that was recently presented at the Heart Failure Society of America conference.
THOR: 63.50 (+0.05)
HeartWare-Valtech Cardio Deal: Engaged Capital Not in Favor
Zacks Equity Research - Zacks Investment Research - Mon Oct 05, 1:45PM CDT
HeartWare Inc.'s (HTWR) Valtech Cardio takeover has been opposed through a letter by one of its top 20 shareholders ??? Engaged Capital
ANF: 17.02 (-0.30), STJ: 78.65 (+0.51), THOR: 63.50 (+0.05), HTWR: 58.20 (+0.22)
St. Jude Faces FDA Warning for Quality Issues at Atlanta Plant
Zacks Equity Research - Zacks Investment Research - Mon Oct 05, 12:50PM CDT
According to Reuters, St. Jude Medical Inc. (STJ) has been recently warned by the FDA regarding the quality of the heart failure monitor CardioMEMS HF systems that are manufactured at its Atlanta plant
MASI: 59.90 (+0.47), STJ: 78.65 (+0.51), THOR: 63.50 (+0.05), NUVA: 66.74 (+0.68)
Cardinal Health Buys Cordis, Fortifies Cardiovascular Hold
Zacks Equity Research - Zacks Investment Research - Mon Oct 05, 12:45PM CDT
Cardinal Health, Inc. (CAH) recently completed the acquisition of Johnson & Johnson's (JNJ) Cordis business unit for $1.944 billion which was announced in March this year
MASI: 59.90 (+0.47), CAH: 79.73 (+0.03), THOR: 63.50 (+0.05), NUVA: 66.74 (+0.68)
C.R. Bard Gains Full Ownership of Medicon, Expands in Japan
Zacks Equity Research - Zacks Investment Research - Fri Oct 02, 11:50AM CDT
Shares of C.R. Bard Inc. (BCR) climbed 2.1% to $190.22, following the signing of a definitive agreement to acquire Kobayashi Pharmaceutical's 50% stake in Medicon.
MASI: 59.90 (+0.47), BCR: 221.21 (-0.29), THOR: 63.50 (+0.05), NUVA: 66.74 (+0.68)
Pacific Biosciences Unveils Sequel System, Boosts Portfolio
Zacks Equity Research - Zacks Investment Research - Thu Oct 01, 3:15PM CDT
Pacific Biosciences of California Inc (PACB) recently launched Sequel system ??? a nucleic acid sequencing platform based on Single Molecule, Real-Time (SMRT) technology
RTIX: 3.40 (+0.08), PACB: 8.28 (-0.02), MASI: 59.90 (+0.47), THOR: 63.50 (+0.05)
Verisk Analytics Set to Join the S&P 500; Joy Global to Join S&P MidCap 400
PR Newswire - Wed Sep 30, 5:05PM CDT
S&P 500 constituent Joy Global Inc. (NYSE: JOY) will replace Thoratec Corp. (NASDAQ: THOR) in the S&P MidCap 400, and Verisk Analytics Inc. (NASDAQ: VRSK) will replace Joy Global in the S&P 500 after the close of trading on Wednesday, October 7. S&P 500 constituent St. Jude Medical Inc. (NYSE: STJ) is acquiring Thoratec in a deal expected to be completed on or about that date, pending final approvals. Joy Global has a market capitalization more representative of the mid-cap market space.
JOY: 27.26 (+0.01), VRSK: 83.84 (+0.54), STJ: 78.65 (+0.51), THOR: 63.50 (+0.05), MHFI: 107.92 (+1.16)
RTI Surgical: A Strong Buy on Q2 Results, Raised 2015 View
Zacks Equity Research - Zacks Investment Research - Wed Sep 30, 3:10PM CDT
On Sep 30, Zacks Investment Research upgraded RTI Surgical Inc. (RTIX) to a Zacks Rank #1 (Strong Buy).
ABMD: 117.43 (-0.20), RTIX: 3.40 (+0.08), MASI: 59.90 (+0.47), THOR: 63.50 (+0.05)
PRA Health, AMR Team Up to Advance Vaccine Studies
Zacks Equity Research - Zacks Investment Research - Wed Sep 30, 12:55PM CDT
PRA Health Sciences, Inc. (PRAH) recently announced a partnership with Alliance for Multispecialty Research (AMR) in order to bring new vaccines in the market
MASI: 59.90 (+0.47), THOR: 63.50 (+0.05), PRAH: 50.38 (-0.18), NUVA: 66.74 (+0.68)
Veeva's Zinc Ahead Deal: Focus on Compliance Management
Zacks Equity Research - Zacks Investment Research - Wed Sep 30, 12:45PM CDT
Provider of cloud-based software solutions, Veeva Systems (VEEV) recently took over Zinc Ahead for $130 million
VEEV: 40.74 (+0.51), MASI: 59.90 (+0.47), THOR: 63.50 (+0.05), NUVA: 66.74 (+0.68)
United States Electromedical and Electrotherapeutic Apparatus Market Report 2016 - Analysis And Forecast to 2020
M2 - Mon Jan 25, 9:03AM CST
Research and Markets (http://www.researchandmarkets.com/research/6mvcjq/u_s) has announced the addition of the "U.S. Electromedical And Electrotherapeutic Apparatus Market - Analysis And Forecast to 2020" report to their offering. The report provides an in-depth analysis of the U.S. Electromedical And Electrotherapeutic Apparatus market. It presents the latest data of the market size and volume, domestic production, exports and imports, price dynamics and turnover in the industry. In addition, the report contains insightful information about the industry, including industry life cycle, business locations, productivity, employment and many other crucial aspects. The Company Profiles section contains relevant data on the major players in the industry. Product coverage: - Electromedical equipment (including diagnostic, therapeutic, and patient monitoring equipment), excluding ionizing radiation equipment - Electronic hearing aids, complete units - Electromedical and electrotherapeutic apparatus manufacturing Key Topics Covered: 1. Introduction 2. Executive Summary 3. Market Overview 4. Domestic Production 5. Imports 6. Exports 7. Competitive Landscape 8. Company Profiles - St. Jude Medical - Zimmer Biomet Holdings - Varian Medical Systems - Medtronic - Hologic - Abbott Vascular - Zoll Medical Corporation - Cyberonics - Fujifilm Sonosite - Biomerieux - Masimo Corporation - Starkey Laboratories - Volcano Corporation - Philips Ultrasound - Thoratec Corporation - Nxstage Medical - Danaher Corporation - Abiomed - GE Medical Systems Information Technologies - Natus Medical Incorporated - Conmed Corporation - Pacesetter - Amplifon (usa) - Zimmer - Cynosure - Mindray Ds Usa - Orchid Orthopedic Solutions - Zoll Services - Datex-Ohmeda - Medtronic Minimed - Terumo Cardiovascular Systems Corporation - Nellcor Puritan Bennett Incorporated - Cardiac Pacemakers - Halyard Sales For more information visit http://www.researchandmarkets.com/research/6mvcjq/u_s
ZBH: 129.40 (+1.05), MASI: 59.90 (+0.47), MDT: 87.32 (+0.34), MDSY: 1.30 (-0.08), DHR: 81.19 (-0.25), CYBX: 69.95 (+0.86), BABY: 40.64 (+0.93), VAR: 96.41 (+0.52), VOLC: 17.99 (+0.01), STJ: 78.65 (+0.51), THOR: 63.50 (+0.05), HOLX: 38.51 (+0.05)
Global Bio-Implant Market 2016-2021 - Increasing awareness about cosmetic implants giving rise to global bio-implant market
M2 - Wed Jan 20, 10:27AM CST
Research and Markets (http://www.researchandmarkets.com/research/7jx486/global) has announced the addition of the "Global Bio-Implant Market, By Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation And Forecast 2015 - 2021" report to their offering. Global bio-implant market is growing at a CAGR of 8% from 2015-2021 The market is driven by various factors which include global rise in adoption of bio-implants, increase in number of people suffering from disabilities. It is giving rise to higher number of amputation. Rising incidence and prevalence rate of CVD, CHD and other heart diseases is also driving the market growth. Additionally, with increasing adoption of prosthetic limbs across geographies and rise in awareness about ear implants, pacemakers and other bio-implants are creating huge scope for global bio-implant market. Market is segmented on the basis of materials which include material such as ceramics, metal, alloys, polymers and others. Global bio-implant market by material and its type are extensively adopted by major hospitals and clinics for bio-implants. Further the market is segmented on the basis of bio implants type which includes CVD implants, spinal implants, orthopedic and trauma, dental, ophthalmic and neurostimulators. Stents, cardiac implant, ear implant are expected to contribute highest among all the segments of global bio-implant market. With the advancement in technology and innovation due to research and development segments such as dental implants, orthopedic implants are expected to contribute better in next few years. Bio-implant market consists of some major companies which includes Medtronic Inc, Abbot laboratories, AAP implantate AG, Bausch & Lomb incorporated, Biomet Inc, Biotronik SE & Co. KG, Boston scientific corporation, Crook group Inc, CR Bard Inc, Toshiba Corporation and others. Key Topics Covered: 1. Introduction 2. Market overview 3. Market determinants 4. Sector Analysis 5. Market Segmentation 6. Competitive Landscape 7. Geographical analysis 8. Company Profiles - Medtronic Inc - Abbot laboratories - AAP implantate AG - Bausch & Lomb incorporated - Biomet Inc - Biotronik SE & Co. KG - Boston scientific corporation - Crook group Inc - CR Bard Inc - Toshiba Corporation - GE healthcare - Edwards lifesciences corporation - Endo health solutions Inc - Johnson & Johnson - Philips corporation - Stryker corporation - Integral lifesciences holdings corporation - Integrated orbital implants - Lifenet health Inc - Mimedx group Inc - Orthofix international N.V. - Smith & nephew, PLC - Zimmer holdings - Wright medical group incorporated - WL Gore & associates Inc - Tornier N.V. - Thoratec corporation - St. Jude medical Inc - Sorin S.P.A. - Intuitive surgicals For more information visit http://www.researchandmarkets.com/research/7jx486/global
JNJ: 119.32 (+0.24), BCR: 221.21 (-0.29), MDT: 87.32 (+0.34), THOR: 63.50 (+0.05), SYK: 115.60 (+0.37)
St. Jude Medical Completes Acquisition of Thoratec
BusinessWire - Thu Oct 08, 3:38PM CDT
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced it has completed the previously announced acquisition of Thoratec Corporation, a worldwide leader in mechanical circulatory support (MCS) technology for the treatment of advanced heart failure (HF).
STJ: 78.65 (+0.51), THOR: 63.50 (+0.05)
Varian (VAR) Receives FDA Clearance, CE Mark for VitalBeam
Zacks Equity Research - Zacks Investment Research - Thu Oct 08, 11:50AM CDT
Varian Medical Systems, Inc. (VAR) recently announced that its VitalBeam platform has received FDA clearance as well as CE Mark.
MASI: 59.90 (+0.47), VAR: 96.41 (+0.52), THOR: 63.50 (+0.05), NUVA: 66.74 (+0.68)
Thoratec's shareholders approves its acquisition by St. Jude Medical
M2 - Thu Oct 08, 5:19AM CDT
Thoratec (NasdaqGS:THOR) said on Wednesday that all proposals necessary for its acquisition by St. Jude Medical were approved at the former's shareholder meeting.
STJ: 78.65 (+0.51), THOR: 63.50 (+0.05)
Thoratec Shareholders Approve St. Jude Medical's Acquisition Of Thoratec
PR Newswire - Wed Oct 07, 3:15PM CDT
Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts, announced today that all proposals necessary for St. Jude Medical, Inc.'s acquisition of Thoratec Corporation were approved by Thoratec Corporation's shareholders at its shareholder meeting held today.
STJ: 78.65 (+0.51), THOR: 63.50 (+0.05)
Varian to Add New Tool to Eclipse Treatment Planning System
Zacks Equity Research - Zacks Investment Research - Wed Oct 07, 1:15PM CDT
Varian Medical Systems Inc. (VAR) recently announced that it will incorporate a multi-criteria optimization (MCO) radiotherapy treatment planning tool into its Eclipse treatment planning system
MASI: 59.90 (+0.47), VAR: 96.41 (+0.52), THOR: 63.50 (+0.05), NUVA: 66.74 (+0.68)
IDEXX's Strong CAG Impresses, Stiff Competition Concerns
Zacks Equity Research - Zacks Investment Research - Tue Oct 06, 5:03PM CDT
On Oct 6 2015, we issued an updated research report on IDEXX Laboratories, Inc. (IDXX).
MASI: 59.90 (+0.47), GMED: 23.97 (+0.51), THOR: 63.50 (+0.05), IDXX: 114.09 (+0.93)
MedAssets: A Strong Buy on Extended Ties & Solid Q2 Results
Zacks Equity Research - Zacks Investment Research - Tue Oct 06, 1:35PM CDT
On Oct 6, Zacks Investment Research raised MedAssets, Inc. (MDAS) to a Zacks Rank #1 (Strong Buy).
MASI: 59.90 (+0.47), THOR: 63.50 (+0.05), MDAS: 31.35 (+0.01), NUVA: 66.74 (+0.68)
Accuray Extends Ties with RaySearch Laboratories, Stock Up
Zacks Equity Research - Zacks Investment Research - Tue Oct 06, 12:10PM CDT
Shares of Accuray Incorporated (ARAY) rallied 3.2% (or 17 cents) yesterday, following the news of its second long-term agreement with RaySearch Laboratories.
MASI: 59.90 (+0.47), THOR: 63.50 (+0.05), ARAY: 5.42 (+0.12), NUVA: 66.74 (+0.68)
Thoratec Highlights Clinical Events From The European Association For Cardio-Thoracic Surgery Conference
PR Newswire - Tue Oct 06, 7:21AM CDT
Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts, highlighted recent clinical presentations from the European Association for Cardio-Thoracic Surgery (EACTS) annual meeting in Amsterdam, including three presentations that build upon the positive initial data from the HeartMate 3 CE Mark trial that was recently presented at the Heart Failure Society of America conference.
THOR: 63.50 (+0.05)
HeartWare-Valtech Cardio Deal: Engaged Capital Not in Favor
Zacks Equity Research - Zacks Investment Research - Mon Oct 05, 1:45PM CDT
HeartWare Inc.'s (HTWR) Valtech Cardio takeover has been opposed through a letter by one of its top 20 shareholders ??? Engaged Capital
ANF: 17.02 (-0.30), STJ: 78.65 (+0.51), THOR: 63.50 (+0.05), HTWR: 58.20 (+0.22)
St. Jude Faces FDA Warning for Quality Issues at Atlanta Plant
Zacks Equity Research - Zacks Investment Research - Mon Oct 05, 12:50PM CDT
According to Reuters, St. Jude Medical Inc. (STJ) has been recently warned by the FDA regarding the quality of the heart failure monitor CardioMEMS HF systems that are manufactured at its Atlanta plant
MASI: 59.90 (+0.47), STJ: 78.65 (+0.51), THOR: 63.50 (+0.05), NUVA: 66.74 (+0.68)
Cardinal Health Buys Cordis, Fortifies Cardiovascular Hold
Zacks Equity Research - Zacks Investment Research - Mon Oct 05, 12:45PM CDT
Cardinal Health, Inc. (CAH) recently completed the acquisition of Johnson & Johnson's (JNJ) Cordis business unit for $1.944 billion which was announced in March this year
MASI: 59.90 (+0.47), CAH: 79.73 (+0.03), THOR: 63.50 (+0.05), NUVA: 66.74 (+0.68)
C.R. Bard Gains Full Ownership of Medicon, Expands in Japan
Zacks Equity Research - Zacks Investment Research - Fri Oct 02, 11:50AM CDT
Shares of C.R. Bard Inc. (BCR) climbed 2.1% to $190.22, following the signing of a definitive agreement to acquire Kobayashi Pharmaceutical's 50% stake in Medicon.
MASI: 59.90 (+0.47), BCR: 221.21 (-0.29), THOR: 63.50 (+0.05), NUVA: 66.74 (+0.68)
Pacific Biosciences Unveils Sequel System, Boosts Portfolio
Zacks Equity Research - Zacks Investment Research - Thu Oct 01, 3:15PM CDT
Pacific Biosciences of California Inc (PACB) recently launched Sequel system ??? a nucleic acid sequencing platform based on Single Molecule, Real-Time (SMRT) technology
RTIX: 3.40 (+0.08), PACB: 8.28 (-0.02), MASI: 59.90 (+0.47), THOR: 63.50 (+0.05)
Verisk Analytics Set to Join the S&P 500; Joy Global to Join S&P MidCap 400
PR Newswire - Wed Sep 30, 5:05PM CDT
S&P 500 constituent Joy Global Inc. (NYSE: JOY) will replace Thoratec Corp. (NASDAQ: THOR) in the S&P MidCap 400, and Verisk Analytics Inc. (NASDAQ: VRSK) will replace Joy Global in the S&P 500 after the close of trading on Wednesday, October 7. S&P 500 constituent St. Jude Medical Inc. (NYSE: STJ) is acquiring Thoratec in a deal expected to be completed on or about that date, pending final approvals. Joy Global has a market capitalization more representative of the mid-cap market space.
JOY: 27.26 (+0.01), VRSK: 83.84 (+0.54), STJ: 78.65 (+0.51), THOR: 63.50 (+0.05), MHFI: 107.92 (+1.16)
RTI Surgical: A Strong Buy on Q2 Results, Raised 2015 View
Zacks Equity Research - Zacks Investment Research - Wed Sep 30, 3:10PM CDT
On Sep 30, Zacks Investment Research upgraded RTI Surgical Inc. (RTIX) to a Zacks Rank #1 (Strong Buy).
ABMD: 117.43 (-0.20), RTIX: 3.40 (+0.08), MASI: 59.90 (+0.47), THOR: 63.50 (+0.05)
PRA Health, AMR Team Up to Advance Vaccine Studies
Zacks Equity Research - Zacks Investment Research - Wed Sep 30, 12:55PM CDT
PRA Health Sciences, Inc. (PRAH) recently announced a partnership with Alliance for Multispecialty Research (AMR) in order to bring new vaccines in the market
MASI: 59.90 (+0.47), THOR: 63.50 (+0.05), PRAH: 50.38 (-0.18), NUVA: 66.74 (+0.68)
Veeva's Zinc Ahead Deal: Focus on Compliance Management
Zacks Equity Research - Zacks Investment Research - Wed Sep 30, 12:45PM CDT
Provider of cloud-based software solutions, Veeva Systems (VEEV) recently took over Zinc Ahead for $130 million
VEEV: 40.74 (+0.51), MASI: 59.90 (+0.47), THOR: 63.50 (+0.05), NUVA: 66.74 (+0.68)
(0)
(0)Scroll down for more posts ▼